Stacie Lindsey Invites to a Webinar on the Latest Cholangiocarcinoma Treatments
Stacie Lindsey, CEO at Cholangiocarcinoma Foundation, shared a post on X: “Register now for the Cholangiocarcinoma Foundation July 9th webinar featuring pharm experts sharing the latest on…
Read the full articleYou might also wanna read
A Phase III Trial of Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
Conditions : Intrahepatic Cholangiocarcinoma (Icc) Interventions : Drug: Gemcitabine; Drug: Cisplatin; Drug: Tislelizumab; Drug: Lenvatinib;
Medscape/PBC Foundation Educational Event: PBC Case Challenges and Solutions
Your patients with primary biliary cholangitis (PBC) may be suffering from itch and fatigue in silence.
mdsc.pe·10d agoHAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
Conditions : Liver Cancer Interventions : Device: DEB-TACE; Drug: Toripalimab; Drug: Lenvatinib; Drug: Gemcitabine; Drug: Oxaliplatin Sponso
Ask HN: What is the latest on treatment of Metastatic Breast Cancer?
I was reading this recently shared post on the promise of CAR-T therapy for cancer[1]. However, it seems that it may not be universally appl
A Study of Combination Therapy in Patients With Resectable Liver Cancer
Conditions : Liver Cancer (Primary and Metastatic) Interventions : Drug: Hepatic Arterial Infusion Chemotherapy Combined with Adebrelimab Pl
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
Scientists have expressed ‘excitement’ over the potential new treatment for advanced adrenocortical carcinoma (ACC)
Comments
Sign in to join the conversation.
No comments yet. Be the first.